Showing results (1601-1610 of 1,641) with videos related to
Sort By:
Pageof 165
Hepatology (Baltimore, Md.)|March 10, 2023
Differential response of HBV envelope-specific CD4 + T cells is related to HBsAg loss after stopping nucleos(t)ide analogue therapyYongyin Li, Chunhua Wen, Shuqin Gu, et al.Signal Transduction and Targeted Therapy|April 20, 2024
A novel engineered IL-21 receptor arms T-cell receptor-engineered T cells (TCR-T cells) against hepatocellular carcinomaWei Zhu, Zhiming Zhang, Jinzhang Chen, et al.Cell Reports|February 27, 2020
Gliomas Interact with Non-glioma Brain Cells via Extracellular VesiclesXiaofei Gao, Zhaohuan Zhang, Tomoyuki Mashimo, et al.The Journal of Experimental Medicine|January 14, 2009
Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- miceRolf Gräbner, Katharina Lötzer, Sandra Döpping, et al.Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|February 18, 2016
[Development of human embryonic stem cell platforms for human health-safety evaluation]Guang-yan Yu, Tong Cao, Xiao-hui Zou, et al.Proceedings of the National Academy of Sciences of the United States of America|June 5, 2023
A spatiotemporal barrier formed by Follistatin is required for left-right patterningXin-Xin Fu, Ding-Hao Zhuo, Ying-Jie Zhang, et al.Plos Biology|November 1, 2022
Mycn regulates intestinal development through ribosomal biogenesis in a zebrafish model of Feingold syndrome 1Yun-Fei Li, Tao Cheng, Ying-Jie Zhang, et al.Respiratory Research|November 15, 2022
Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram constructionYuqin Chen, Dansha Zhou, Mingmei Xiong, et al.Science Translational Medicine|February 25, 2021
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunityYuzhu Hou, Hua L Liang, Xinshuang Yu, et al.The Journal of Clinical Investigation|May 20, 2014
Targeting CD137 enhances the efficacy of cetuximabHolbrook E Kohrt, A Dimitrios Colevas, Roch Houot, et al.Pageof 165